Publikationen zu speziellen Erkrankungen aus der Hämatologie und Hämostasiologie

Hier finden Sie eine Zusammenstellung wichtiger nationaler und internationaler Publikationen zu den einzelnen hämatologischen Erkrankungen im Kindes- und Jugendalter.

Autor:  Julia Dobke, Redaktion:  Julia Dobke, Zuletzt geändert: 13.12.2023 https://kinderblutkrankheiten.de/doi/e103138

Anämien

Übersichtsartikel Anämien

  1. Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA: Five hematologic tests and treatments to question. Blood 2014, 124: 3524 [PMID: 25472968] HIC2014
  2. Hicks LK, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Pasquini M, Sarode R, Solberg L Jr, Haynes AE, Crowther MA: The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood 2013, 122: 3879 [PMID: 24307720] HIC2013
  3. Milman N: Anemia--still a major health problem in many parts of the world!. Ann Hematol 2011, 90: 369 [PMID: 21221586] MIL2011

Literatur zur Autoimmunhämolytischen Anämie (AIHA)

  1. Cavallaro F, Barcellini W, Fattizzo B: Antibody based therapeutics for autoimmune hemolytic anemia. Expert opinion on biological therapy 2023,: 1 [PMID: 37874225] CAV2023
  2. Blackall D, Dolatshahi L: Autoimmune Hemolytic Anemia in Children: Laboratory Investigation, Disease Associations, and Treatment Strategies. Journal of pediatric hematology/oncology 2022, 44: 71 [PMID: 35235549] BLA2022
  3. Berentsen S, Tjønnfjord GE: Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood reviews 2012, [Epub ahead of print] [PMID: 22330255] BER2012
  4. Garbe E, Andersohn F, Bronder E, Klimpel A, Thomae M, Schrezenmeier H, Hildebrandt M, Späth-Schwalbe E, Grüneisen A, Mayer B, Salama A, Kurtal H: Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study. British journal of haematology 2011, 154: 644 [PMID: 21749359] GAR2011
  5. Aladjidi N, Leverger G, Leblanc T, Picat MQ, Michel G, Bertrand Y, Bader-Meunier B, Robert A, Nelken B, Gandemer V, Savel H, Stephan JL, Fouyssac F, Jeanpetit J, Thomas C, Rohrlich P, Baruchel A, Fischer A, Chêne G, Perel Y, Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE): New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica 2011, 96: 655 [PMID: 21228033] ALA2011
  6. Pruss A, Salama A, Ahrens N, Hansen A, Kiesewetter H, Koscielny J, Dörner T: Immune hemolysis-serological and clinical aspects. Clinical and experimental medicine 2003, 3: 55 [PMID: 14598182] PRU2003

Literatur zur Diamond-Blackfan-Anämie

  1. Bhoopalan SV, Suryaprakash S, Sharma A, Wlodarski MW: Hematopoietic cell transplantation and gene therapy for Diamond-Blackfan anemia: state of the art and science. Frontiers in oncology 2023, 13: 1236038 [PMID: 37752993] BHO2023
  2. Liu Y, Karlsson S: Perspectives of current understanding and therapeutics of Diamond-Blackan anemia. Leukemia 2023, [PMID: 37973818] LIU2023
  3. de Wilde JRA, van Dooijeweert B, van Vuren AJ, Huisman EJ, Smiers FJ, van der Veer A, van Wijk R, van Solinge WW, Nieuwenhuis EES, van Beers EJ, Bartels M: Transfusion burden in early childhood plays an important role in iron overload in Diamond-Blackfan anaemia. EJHaem 2022, 3: 1300 [PMID: 36467824] WIL2022
  4. Miano M, Eikema DJ, de la Fuente J, Bosman P, Ghavamzadeh A, Smiers F, Sengeløv H, Yesilipek A, Formankova R, Bader P, Díaz Pérez MÁ, Bertrand Y, Niemeyer C, Diallo S, Ansari M, Bykova TA, Faraci M, Bonanomi S, Gozdzik J, Satti TM, Bodova I, Wölfl M, Rocha VG, Mellgren K, Rascon J, Holter W, Lange A, Meisel R, Beguin Y, Mozo Y, Kriván G, Sirvent A, Bruno B, Dalle JH, Onofrillo D, Giardino S, Risitano AM, de Latour RP, Dufour C: Stem Cell Transplantation for Diamond-Blackfan Anemia. A Retrospective Study on Behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT). Transplantation and cellular therapy 2021, 27: 274.e1-274.e5 [PMID: 33781541] MIA2021
  5. Strahm B, Loewecke F, Niemeyer CM, Albert M, Ansari M, Bader P, Bertrand Y, Burkhardt B, Da Costa LM, Ferster A, Fischer A, Güngör T, Gruhn B, Hainmann I, Kapp F, Lang P, Müller I, Schulz A, Szvetnik A, Wlodarski M, Noellke P, Leblanc T, Dalle JH: Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemia. Blood advances 2020, 4: 1760 [PMID: 32343795] STR2020a
  6. Da Costa L, Leblanc T, Mohandas N: Diamond-Blackfan anemia. Blood 2020, 136: 1262 [PMID: 32702755] DAC2020
  7. Vlachos A, Muir E: How I treat Diamond-Blackfan anemia. Blood 2010, 116: 3715 [PMID: 20651069] VLA2009
  8. Vlachos A, Ball S, Dahl N, Alter BP, Sheth S, Ramenghi U, Meerpohl J, Karlsson S, Liu JM, Leblanc T, Paley C, Kang EM, Leder EJ, Atsidaftos E, Shimamura A, Bessler M, Glader B, Lipton JM, Participants of Sixth Annual Daniella Maria Arturi International Consensus Conference: Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. British journal of haematology 2008, 142: 859 [PMID: 18671700] VLA2008
  9. Faivre L, Meerpohl J, Da Costa L, Marie I, Nouvel C, Gnekow A, Bender-Götze C, Bauters F, Coiffier B, Peaud PY, Rispal P, Berrebi A, Berger C, Flesch M, Sagot P, Varet B, Niemeyer C, Tchernia G, Leblanc T: High-risk pregnancies in Diamond-Blackfan anemia: a survey of 64 pregnancies from the French and German registries. Haematologica 2006, 91: 530 [PMID: 16537118] FAI2006

Literatur zur Dyserythropoetischen Anämie

  1. Grandchamp B, Hetet G, Kannengiesser C, Oudin C, Beaumont C, Rodrigues-Ferreira S, Amson R, Telerman A, Nielsen P, Kohne E, Balser C, Heimpel H: A novel type of congenital hypochromic anemia associated with a nonsense mutation in the STEAP3/TSAP6 gene. Blood 2011, 118: 6660 [PMID: 22031863] GRA2011b
  2. Schwarz K, Iolascon A, Verissimo F, Trede NS, Horsley W, Chen W, Paw BH, Hopfner KP, Holzmann K, Russo R, Esposito MR, Spano D, De Falco L, Heinrich K, Joggerst B, Rojewski MT, Perrotta S, Denecke J, Pannicke U, Delaunay J, Pepperkok R, Heimpel H: Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nature genetics 2009, 41: 936 [PMID: 19561605] SCH2009h
  3. Heimpel H, Anselstetter V, Chrobak L, Denecke J, Einsiedler B, Gallmeier K, Griesshammer A, Marquardt T, Janka-Schaub G, Kron M, Kohne E: Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood 2003, 102: 4576 [PMID: 12933587] HEI2003
  4. Wickramasinghe SN: Congenital dyserythropoietic anaemias: clinical features, haematological morphology and new biochemical data. Blood reviews 1998, 12: 178 [PMID: 9745888] WIC1998

Literatur zur Fanconi-Anämie

  1. Satty AM, Klein E, Mauguen A, Kunvarjee B, Boelens JJ, Cancio M, Curran KJ, Kernan NA, Prockop SE, Scaradavou A, Spitzer B, Tamari R, Ruggiero J, Torok-Castanza J, Mehta PA, O'Reilly RJ, Boulad F: T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML. Bone marrow transplantation 2023, [PMID: 37773270] SAT2023
  2. Cancio M, Troullioud Lucas AG, Bierings M, Klein E, de Witte MA, Smiers FJ, Bresters D, Boelens JJ, Smetsers SE: Predictors of outcomes in hematopoietic cell transplantation for Fanconi anemia. Bone marrow transplantation 2023, [PMID: 37848556] CAN2023
  3. Behrens YL, Göhring G, Bawadi R, Cöktü S, Reimer C, Hoffmann B, Sänger B, Käfer S, Thol F, Erlacher M, Niemeyer CM, Baumann I, Kalb R, Schindler D, Kratz CP: A novel classification of hematologic conditions in patients with Fanconi anemia. Haematologica 2021, Online ahead of print [PMID: 34196171] BEH2021
  4. Giardino S, de Latour RP, Aljurf M, Eikema DJ, Bosman P, Bertrand Y, Tbakhi A, Holter W, Bornhäuser M, Rössig C, Burkhardt B, Zecca M, Afanasyev B, Michel G, Ganser A, Alseraihy A, Ayas M, Uckan-Cetinkaya D, Bruno B, Patrick K, Bader P, Itälä-Remes M, Rocha V, Jubert C, Diaz MA, Shaw PJ, Junior LGD, Locatelli F, Kröger N, Faraci M, Pierri F, Lanino E, Miano M, Risitano A, Robin M, Dufour C, Severe Aplastic Anemia and Chronic Malignancies Working Parties of European Blood and Marrow Transplantation group: Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group. American journal of hematology 2020, 95: 809 [PMID: 32267023] GIA2020
  5. Chao MM, Thomay K, Goehring G, Wlodarski M, Pastor V, Schlegelberger B, Schindler D, Kratz CP, Niemeyer C: Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms. Klinische Padiatrie 2017, 229: 329 [PMID: 29132164] CHA2017
  6. Paul U, Richter J, Stuhlmann-Laiesz C, Kreuz M, Nagel I, Horn H, Staiger AM, Aukema SM, Hummel M, Ott G, Spang R, Rosenwald A, Feller AC, Cogliatti S, Stein H, Hansmann ML, Moller P, Szczepanowski M, Burkhardt B, Pfreundschuh M, Schmitz N, Loeffler M, Truemper L, Siebert R, Klapper W: Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC. Leukemia & lymphoma 2018, 59: 1213 [PMID: 28838257] PAU2017
  7. Chao MM, Kuehl JS, Strauss G, Hanenberg H, Schindler D, Neitzel H, Niemeyer C, Baumann I, von Bernuth H, Rascon J, Nagy M, Zimmermann M, Kratz CP, Ebell W: Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only. Annals of hematology 2015, 94: 1311 [PMID: 25862235] CHA2015
  8. Alter BP: Fanconi anemia and the development of leukemia. Best practice & research. Clinical haematology 2014, 27(3-4): 214 [PMID: 25455269] ALT2014
  9. Yoshimi A, Niemeyer C, Baumann I, Schwarz-Furlan S, Schindler D, Ebell W, Strahm B: High incidence of Fanconi anaemia in patients with a morphological picture consistent with refractory cytopenia of childhood. British journal of haematology 2013, 160: 109 [PMID: 23043447] YOS2013a
  10. Myers K, Davies SM, Harris RE, Spunt SL, Smolarek T, Zimmerman S, McMasters R, Wagner L, Mueller R, Auerbach AD, Mehta PA: The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations. Pediatric blood & cancer 2012, 58: 462 [PMID: 21548014] MYE2012

Literatur zur sekundären Eisenüberladung

  1. Cario H, Grosse R, Janssen G, Jarisch A, Meerpohl J, Strauss G, German hematology societies (GPOH and DGHO): [Guidelines for diagnosis and treatment of secondary iron overload in patients with congenital anemia]. Klinische Padiatrie 2010, 222: 399 [PMID: 20862634] CAR2010a

Literatur zur Sichelzellkrankheit

  1. Mañú Pereira MDM, Colombatti R, Alvarez F, Bartolucci P, Bento C, Brunetta AL, Cela E, Christou S, Collado A, de Montalembert M, Dedeken L, Fenaux P, Galacteros F, Glenthøj A, Gutiérrez Valle V, Kattamis A, Kunz J, Lobitz S, McMahon C, Pellegrini M, Reidel S, Russo G, Santos Freire M, van Beers E, Kountouris P, Gulbis B: Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective. The Lancet 2023, 10:e687-e694 [PMID: 37451300] PER2023a
  2. Eapen M, Brazauskas R, Williams DA, Walters MC, St Martin A, Jacobs BL, Antin JH, Bona K, Chaudhury S, Coleman-Cowger VH, DiFronzo NL, Esrick EB, Field JJ, Fitzhugh CD, Kanter J, Kapoor N, Kohn DB, Krishnamurti L, London WB, Pulsipher MA, Talib S, Thompson AA, Waller EK, Wun T, Horowitz MM: Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023, 41: 2227 [PMID: 36623245] EAP2023
  3. Allard P, Alhaj N, Lobitz S, Cario H, Jarisch A, Grosse R, Oevermann L, Hakimeh D, Tagliaferri L, Kohne E, Kopp-Schneider A, Kulozik AE, Kunz JB: Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea. Haematologica 2022, 107: 1577 [PMID: 34706496] ALL2022
  4. Lobitz S, Frömmel C, Brose A, Blankenstein O, Turner C, Dalton RN, Daniel Y, Klein J: Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol. Annals of hematology 2022, 101: 1859 [PMID: 35293609] LOB2022
  5. Sharpe CC, Suddle A, Stuart-Smith S: An Overview of Solid Organ Transplantation in Patients With Sickle Cell Disease. Transplantation 2023, 107: 596 [PMID: 36210501] WAL2022
  6. Walter O, Cougoul P, Maquet J, Bartolucci P, Lapeyre-Mestre M, Lafaurie M, Moulis G: Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease. Blood 2022, 139: 3771 [PMID: 35471555] WAL2022
  7. Dela-Pena JC, King MA, Brown J, Nachar VR: Incorporation of novel therapies for the management of sickle cell disease: A pharmacist's perspective. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2022, 28: 646 [PMID: 35060419] DEL2022
  8. Kunz JB, Schlotmann A, Daubenbüchel A, Lobitz S, Jarisch A, Grosse R, Cario H, Oevermann L, Hakimeh D, Tagliaferri L, Kulozik AE: Benefits of a Disease Management Program for Sickle Cell Disease in Germany 2011-2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome. Journal of clinical medicine 2021, 10 [PMID: 34640578] KUN2021
  9. : LOB2021
  10. Lobitz S, Kunz JB, Cario H, Hakimeh D, Jarisch A, Kulozik AE, Oevermann L, Grosse R: Introduction of Universal Newborn Screening for Sickle Cell Disease in Germany-A Brief Narrative Review. International journal of neonatal screening 2021, 7 [PMID: 33525323] LOB2021
  11. Henry ER, Metaferia B, Li Q, Harper J, Best RB, Glass KE, Cellmer T, Dunkelberger EB, Conrey A, Thein SL, Bunn HF, Eaton WA: Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin. Blood 2021, Online ahead of print [PMID: 34197597] HEN2021
  12. Gaartman AE, Sayedi AK, Gerritsma JJ, de Back TR, van Tuijn CF, Tang MW, Heijboer H, de Heer K, Biemond BJ, Nur E: Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors. British journal of haematology 2021, Online ahead of print [PMID: 34263922] GAA2021
  13. Kunz JB, Lobitz S, Grosse R, Oevermann L, Hakimeh D, Jarisch A, Cario H, Beier R, Schenk D, Schneider D, Groß-Wieltsch U, Prokop A, Heine S, Khurana C, Erlacher M, Dürken M, Linke C, Frühwald M, Corbacioglu S, Claviez A, Metzler M, Ebinger M, Full H, Wiesel T, Eberl W, Reinhard H, Tagliaferri L, Allard P, Karapanagiotou-Schenkel I, Rother LM, Beck D, Le Cornet L, Kulozik AE, German Sickle Cell Disease Registry: Sickle cell disease in Germany: Results from a national registry. Pediatric blood & cancer 2020, 67:e28130 [PMID: 31867835] KUN2020
  14. Hammoudi N, Lionnet F, Redheuil A, Montalescot G: Cardiovascular manifestations of sickle cell disease. Eur heart j 2020, 41: 1365 [PMID: 31005979] HAM2020
  15. Partanen M, Kang G, Wang WC, Krull K, King AA, Schreiber JE, Porter JS, Hodges J, Hankins JS, Jacola LM: Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease. Br J Haematol 2020 Feb 26; ePup [PMID: 32103506] PAR2020
  16. Krishnamurti L: Should young children with sickle cell disease and an available human leukocyte antigen identical sibling donor be offered hematopoietic cell transplantation? Hematol Oncol Stem Cell Ther 2020 Mar 12; ePub [PMID: 32202246] KRI2020
  17. Ballas SK: The Evolving Pharmacotherapeutic Landscape for the Treatment of Sickle Cell Disease. Mediterr J Hematol Infect Dis 2020, 12:e2020010 [PMID: 31934320] BAL2020
  18. Zeng L, Wang C, Jiang M, Chen K, Zhong H, Chen Z, Huang L, Li H, Zhang L, Choonara I: Safety of ceftriaxone in paediatrics: a systematic review. Archives of disease in childhood 2020 Mar 6; ePub [PMID: 32144089] ZEN2020
  19. Hariharan N, Brunson A, Mahajan A, Keegan THM, Wun T: Bleeding in patients with sickle cell disease: a population-based study. Blood advances 2020, 10; 4: 793 [PMID: 32108229] HAR2020
  20. Driss F, Hequet O: Red blood cell exchange techniques and methods. Transfus apher sci 2019, 58: 132 [PMID: 30910617] DRI2019
  21. Aich A, Jones MK, Gupta K: Pain and sickle cell disease. Current opinion in hematology 2019, 26: 131 [PMID: 30893088] AIC2019
  22. Pirenne F: Prevention of delayed hemolytic transfusion reaction. Transfus clin biol 2019, 26: 99 [PMID: 30926306] PIR2019
  23. Streetly A, Sisodia R, Dick M, Latinovic R, Hounsell K, Dormandy E: Evaluation of newborn sickle cell screening programme in England: 2010-2016. Archives of disease in childhood 2017 [PMID: 29104181] STE2017
  24. Do BK, Rodger DC: Sickle cell disease and the eye. Current opinion in ophthalmology 2017, 28: 623 [PMID: 28984727] ROD2017
  25. Ballas SK: The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive Crises. Cannabis and cannabinoid research 2017, 2: 197 [PMID: 29082316] BAL2017
  26. Davis BA, Allard S, Qureshi A, Porter JB, Pancham S, Win N, Cho G, Ryan K, British Committee for Standards in Haematology: Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects. British journal of haematology 2017, 176: 179 [PMID: 28092109] DAV2017
  27. Foell J, Pfirstinger B, Rehe K, Wolff D, Holler E, Corbacioglu S: Haploidentical stem cell transplantation with CD3+-/CD19+- depleted peripheral stem cells for patients with advanced stage sickle cell disease and no alternative donor: results of a pilot study. Bone marrow transplantation 2017, 52: 938 [PMID: 28436975] FOE2017
  28. Adams RJ, Cox M, Ozark SD, Kanter J, Schulte PJ, Xian Y, Fonarow GC, Smith EE, Schwamm LH: Coexistent Sickle Cell Disease Has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke: Findings From Get With The Guidelines-Stroke. Stroke 2017, 48: 686 [PMID: 28183857] ADA2017
  29. Piel FB, Steinberg MH, Rees DC: Sickle Cell Disease. The New England journal of medicine 2017, 376: 1561 [PMID: 28423290] PIE2017
  30. Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, Pinto Simões B, Ferster A, Dupont S, de la Fuente J, Dalle JH, Zecca M, Walters MC, Krishnamurti L, Bhatia M, Leung K, Yanik G, Kurtzberg J, Dhedin N, Kuentz M, Michel G, Apperley J, Lutz P, Neven B, Bertrand Y, Vannier JP, Ayas M, Cavazzana M, Matthes-Martin S, Rocha V, Elayoubi H, Kenzey C, Bader P, Locatelli F, Ruggeri A, Eapen M, Eurocord, the Pediatric Working Party of the European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research: Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood 2017, 129: 1548 [PMID: 27965196] GLU2017
  31. Habibi A, Mekontso-Dessap A, Guillaud C, Michel M, Razazi K, Khellaf M, Chami B, Bachir D, Rieux C, Melica G, Godeau B, Galacteros F, Bartolucci P, Pirenne F: Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes. American journal of hematology 2016, 91: 989 [PMID: 27348613] HAB2016
  32. Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N: A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. Blood 2016, 128: 2561 [PMID: 27625358] SHE2016
  33. Dumas G, Habibi A, Onimus T, Merle JC, Razazi K, Mekontso Dessap A, Galactéros F, Michel M, Frémeaux Bacchi V, Noizat Pirenne F, Bartolucci P: Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients. Blood 2016, 25; 127: 1062 [PMID: 26758914] DUM2016
  34. Robinson TM, Fuchs EJ: Allogeneic stem cell transplantation for sickle cell disease. Current opinion in hematology 2016, 23: 524 [PMID: 27496639] ROB2016
  35. Danaee A, Inusa B, Howard J, Robinson S: Hyperhemolysis in Patients With Hemoglobinopathies: A Single-Center Experience and Review of the Literature. Transfusion medicine reviews 2015, 29: 220 [PMID: 26209603] DAN2015a
  36. Lê PQ, Gulbis B, Dedeken L, Dupont S, Vanderfaeillie A, Heijmans C, Huybrechts S, Devalck C, Efira A, Dresse MF, Rozen L, Benghiat FS, Ferster A: Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment. Pediatric blood & cancer 2015, 62: 1956 [PMID: 26173735] FER2015
  37. Frömmel C, Brose A, Klein J, Blankenstein O, Lobitz S: Newborn screening for sickle cell disease: technical and legal aspects of a German pilot study with 38,220 participants. BioMed research international 2014, 2014, 695828 [PMID: 25147811] FRO2015
  38. Tormey CA, Hendrickson JE: Routine non-ABO blood group antigen genotyping in sickle cell disease: the new frontier in pretransfusion testing? Transfusion 2015, 55(6 Pt 2): 1374 [PMID: 26094720] TOR2015
  39. Gualandro SF, Fonseca GH, Yokomizo IK, Gualandro DM, Suganuma LM: Cohort study of adult patients with haemoglobin SC disease: clinical characteristics and predictors of mortality. British journal of haematology 2015, 125: 3401 [PMID: 26255986] GUA2015
  40. Bhatia M, Sheth S: Hematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerations. Journal of blood medicine 2015, 6: 229 [PMID: 26203293] BHA2015
  41. Minniti CP, Kato GJ: Critical Reviews: How we treat sickle cell patients with leg ulcers. American journal of hematology 2015, [PMID: 26257201] MIN2015
  42. Alvarez O, Rodriguez MM, Jordan L, Sarnaik S: Renal medullary carcinoma and sickle cell trait: A systematic review. Pediatric blood & cancer 2015, 62: 1694 [PMID: 26053587] ALV2015
  43. Brandow AM, Farley RA, Panepinto JA: Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature. Pediatric blood & cancer 2015, 62: 1501 [PMID: 25976161] BRA2015
  44. De Franceschi L, Mura P, Schweiger V, Vencato E, Quaglia FM, Delmonte L, Evangelista M, Polati E, Olivieri O, Finco G: Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease. Pain practice 2015, Epub ahead of print [PMID: 26009799] DEF2015
  45. Conran N: High Foetal Haemoglobin in Sickle Cell Disease: Not so Protective? EBioMedicine 2015, 2: 102 [PMID: 26137548] CON2015
  46. Fasano RM, Meier ER, Hulbert ML: Cerebral vasculopathy in children with sickle cell anemia. Blood cells, molecules & diseases 2015, 54: 17 [PMID: 25294561] FAS2015
  47. Brousse V, Buffet P, Rees D: The spleen and sickle cell disease: the sick(led) spleen. British journal of haematology 2014, 166: 165 [PMID: 24862308] BRO2014a
  48. Lobitz S, Frömmel C, Brose A, Klein J, Blankenstein O: Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany. European journal of human genetics 2014, 22: 1051 [PMID: 24398797] LOB2014
  49. Nickel RS, Hendrickson JE, Haight AE: The ethics of a proposed study of hematopoietic stem cell transplant for children with . Blood 2014, 124: 861 [PMID: 24963044] NIC2014
  50. Gokarn N, Manwani D, Friedmann P, Borenstein SH, Jan D, Renaud E: Outcomes after early splenectomy for hematological disorders. Journal of laparoendoscopic & advanced surgical techniques. Part A 2014, 24: 897 [PMID: 25275796] GOK2014
  51. Crosby LE, Shook LM, Ware RE, Brinkman WB: Shared decision making for hydroxyurea treatment initiation in children with sickle cell anemia. Pediatric blood & cancer 2014, Epub ahead of print [PMID: 25308571] CRO2014
  52. Hirst C, Owusu-Ofori S: Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. The Cochrane database of systematic reviews 2014, 11:CD003427 [PMID: 25375222] HIR2014
  53. Inusa B, Casale M, Booth C, Lucas S: Subarachnoid haemorrhage and cerebral vasculopathy in a child with sickle cell anaemia. BMJ case reports 2014, [PMID: 25336550] INU2014
  54. Telen MJ, Afenyi-Annan A, Garrett ME, Combs MR, Orringer EP, Ashley-Koch AE: Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival. Transfusion 2014, Epub ahead of print [PMID: 25444611] TEL2014
  55. Meerpohl JJ, Schell LK, Rücker G, Motschall E, Fleeman N, Niemeyer CM, Bassler D: Deferasirox for managing transfusional iron overload in people with sickle cell disease. The Cochrane database of systematic reviews 2014, 5:CD007477 [PMID: 24893174] MEE2014
  56. Silva Junior GB, Vieira AP, Couto Bem AX, Alves MP, Meneses GC, Martins AM, Araújo SM, Libório AV, Daher EF: Proteinuria in adults with sickle-cell disease: the role of hydroxycarbamide(hydroxyurea) as a protective agent. International journal of clinical pharmacy 2014, 36: 766 [PMID: 24934760] SIL2014
  57. Wykes C, Arasaretnam A, O'Driscoll S, Farnham L, Moniz C, Rees DC: Vitamin D deficiency and its correction in children with sickle cell anaemia. Annals of hematology 2014, [PMID: 24981689] WYK2014
  58. Aguilar Martinez P, Angastiniotis M, Eleftheriou A, Gulbis B, Mañú Pereira Mdel M, Petrova-Benedict R, Corrons JL: Haemoglobinopathies in Europe: health & migration policy perspectives. Orphanet journal of rare diseases 2014, 9: 97 [PMID: 24980780] AGU2014
  59. Adams RJ: Prevention of stroke in sickle cell anemia. The Journal of law, medicine & ethics 2014, 42: 135 [PMID: 25040376] ADA2014
  60. Hsieh MM, Fitzhugh CD, Weitzel RP, Link ME, Coles WA, Zhao X, Rodgers GP, Powell JD, Tisdale JF: Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. JAMA 2014, 312: 48 [PMID: 25058217] HSI2014
  61. Nickel RS, Hendrickson JE, Haight AE: The ethics of a proposed study of hematopoietic stem cell transplant for children with . Blood 2014, 124: 861 [PMID: 24963044] NIC2014
  62. Gladwin MT, Barst RJ, Gibbs JS, Hildesheim M, Sachdev V, Nouraie M, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Berman Rosenzweig E, Badesch DB, Lanzkron S, Castro OL, Taylor JG 6th, Goldsmith JC, Kato GJ, Gordeuk VR, Machado RF, walk-PHaSST Investigators and Patients: Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom. PloS one 2014, 9:e99489 [PMID: 24988120] GLA2014
  63. Ulph F, Cullinan T, Qureshi N, Kai J: Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening. European journal of human genetics : EJHG 2014 [PMID: 25005733] ULP2014
  64. Silva Junior GB, Vieira AP, Couto Bem AX, Alves MP, Meneses GC, Martins AM, Sanches TR, Andrade LC, Seguro AC, Libório AB, Daher EF: Renal Tubular Dysfunction in Sickle Cell Disease. Kidney & blood pressure research 2014, 38: 1 [PMID: 24504378] SIL2014
  65. Dowling MM, Noetzel MJ, Rodeghier MJ, Quinn CT, Hirtz DG, Ichord RN, Kwiatkowski JL, Roach ES, Kirkham FJ, Casella JF, Debaun MR: Headache and Migraine in Children with Sickle Cell Disease Are Associated with Lower Hemoglobin and Higher Pain Event Rates But Not Silent Cerebral Infarction. The Journal of pediatrics 2014, E-pub ahead of print [PMID: 24529619] DOW2014
  66. Dedeken L, Lê PQ, Azzi N, Brachet C, Heijmans C, Huybrechts S, Devalck C, Ngalula M, Ferster A: Haematopoietic stem cell transplantation for severe sickle cell disease in childhood: a single centre experience of 50 patients. British journal of haematology 2014,Epub ahead of print [PMID: 24433465] DED2014
  67. Rhodes MM, Bates DG, Andrews T, Adkins L, Thornton J, Denham JM: Abdominal pain in children with sickle cell disease. Journal of clinical gastroenterology 2014, 48: 99 [PMID: 24247814] RHO2014
  68. Ware RE: Hydroxycarbamide: Clinical aspects. Comptes rendus biologies 2013, 336: 177 [PMID: 23643402] WAR2013a
  69. Quinn CT: Sickle cell disease in childhood: from newborn screening through transition to adult medical care. Pediatric clinics of North America 2013, 60: 1363 [PMID: 24237976] QUI2013
  70. Manwani D, Frenette PS: Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies. Blood 2013, 122: 3892 [PMID: 24052549] MAN2013
  71. McGann PT, Nero AC, Ware RE: Current management of sickle cell anemia. Cold Spring Harbor perspectives in medicine 2013, 3 [PMID: 23709685] MCG2013
  72. Majumdar S, Thompson W, Ahmad N, Gordon C, Addison C: The use and effectiveness of complementary and alternative medicine for pain in sickle cell anemia. Complementary therapies in clinical practice 2013, 19: 184 [PMID: 24199970] MAJ2013
  73. Bodas P, Huang A, O Riordan MA, Sedor JR, Dell KM: The prevalence of hypertension and abnormal kidney function in children with sickle cell disease --a cross sectional review. BMC nephrology 2013, 14: 237 [PMID: 24168027] BOD2013
  74. Uprety D, Baber A, Foy M: Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature. Annals of hematology 2013, epub ahead of print [PMID: 24232306] UPR2013
  75. Naik RP, Streiff MB, Haywood C Jr, Nelson JA, Lanzkron S: Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication. The American journal of medicine 2013, 126: 443 [PMID: 23582935] NAI2013
  76. Sommet J, Missud F, Holvoet L, Ithier G, Lorrot M, Benkerrou M, Faye A: Morbidity among child travellers with sickle-cell disease visiting tropical areas: an observational study in a French tertiary care centre. Archives of disease in childhood 2013, epub ahead of print [PMID: 23661574] SOM2013
  77. Mynarek M, Bettoni da Cunha Riehm C, Brinkmann F, Weißenborn K, Tell-Lüersen M, Heuft HG, Maecker-Kolhoff B, Sykora KW: Normalized Transcranial Doppler Velocities, Stroke Prevention and Improved Pulmonary Function after Stem Cell Transplantation in Children with Sickle Cell Anemia. Klinische Padiatrie 2013, 225: 127 [PMID: 23625683] MYN2013
  78. Hamideh D, Alvarez O: Sickle Cell Disease Related Mortality in the United States (1999-2009). Pediatric blood & cancer 2013, epub ahead of print [PMID: 23637037] HAM2013
  79. Ballas SK, Gupta K, Adams-Graves P: Sickle cell pain: a critical reappraisal. Blood 2012, 120: 3647 [PMID: 22923496] BAL2012a
  80. Strouse JJ, Heeney MM: Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children. Pediatric blood & cancer 2012, 59: 365 [PMID: 22517797] STR2012
  81. Rodeghiero F, Ruggeri M: Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications? British journal of haematology 2012l; 158: 16 [PMID: 22571181] ROD2012
  82. Lucarelli G, Isgro`, A, Sodani P, Gaziev, J: Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Anemia. Cold Spring Harb Perspect Med 2012, 2: a011825 [PMID: 22553502] LUC2012
  83. Smith-Whitley, Kim, Thompson, Alexis A : Indications and complications of transfusions in sickle cell disease. Pediatric blood & cancer 2012, 59, 358 [DOI: 10.1002/pbc.24179] SMI2012
  84. Locatelli F, Pagliara D: Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease. Pediatric blood & cancer 2012, 59: 372 [PMID: 22544533] LOC2012
  85. Maigne G, Ferlicot S, Galacteros F, Belenfant X, Ulinski T, Niaudet P, Ronco P, Godeau B, Durrbach A, Sahali S, Lang P, Lambotte O, Audard V: Glomerular lesions in patients with sickle cell disease. Medicine 2010, 89: 18 [PMID: 20075701] MAI2010
  86. National Toxicology Program: NTP-CERHR monograph on the potential human reproductive and developmental effects of hydroxyurea. NTP CERHR MON 2008,:vii-viii, v, ix-III1 [PMID: 19407858] NAT2008

Literatur zu Thalassämien

  1. Makowska A, Lelabi N, Nothbaum C, Shen L, Busson P, Tran TTB, Eble M, Kontny U: Radiotherapy Combined with PD-1 Inhibition Increases NK Cell Cytotoxicity towards Nasopharyngeal Carcinoma Cells. Cells 2021, 10 [PMID: 34572108] MAK2021
  2. Taher AT, Musallam KM, Cappellini MD: β-Thalassemias. Reply. The New England journal of medicine 2021, 384: 2166 [PMID: 34077657] TAH2021
  3. Makis A, Voskaridou E, Papassotiriou I, Hatzimichael E: Novel Therapeutic Advances in β-Thalassemia. Biology 2021, 10 [PMID: 34207028] MAK2021
  4. Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A, BELIEVE Investigators: A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia. N Engl journal of Med 2020, 26; 382: 1219 [PMID: 32212518] CAP2020
  5. Angastiniotis M, Lobitz S: Thalassemias: An Overview. International journal of neonatal screening 2019, 5: 16 [PMID: 33072976] ANG2019
  6. Piga A, Perrotta S, Gamberini MR, Voskaridou E, Melpignano A, Filosa A, Caruso V, Pietrangelo A, Longo F, Tartaglione I, Borgna-Pignatti C, Zhang X, Laadem A, Sherman ML, Attie KM: Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with ß-thalassemia. Blood 2019, 133: 1279 [PMID: 30617198] PIG2019
  7. Farashi S, Harteveld CL: Molecular basis of α-thalassemia. Blood cells, molecules & diseases 2017 [PMID: 29032940] FAR2017
  8. Baronciani D, Angelucci E, Potschger U, Gaziev J, Yesilipek A, Zecca M, Orofino MG, Giardini C, Al-Ahmari A, Marktel S, de la Fuente J, Ghavamzadeh A, Hussein AA, Targhetta C, Pilo F, Locatelli F, Dini G, Bader P, Peters C: Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010. Bone Marrow Transplant 2016 [Epub ahead of print] [PMID: 26752139] BAR2016
  9. Mashhadi MA, Heidari Z, Sepehri Z, Bakhshipour AR, Karimkoshte A: The selenium status in thalassemia patients in South East of iran. Int J Hematol Oncol Stem Cell Res 2014 Oct 1; 8: 1 [PMID: 25774261] MAS2014
  10. Origa R, Sollaino MC, Borgna-Pignatti C, Piga A, Feliu Torres A, Masile V, Galanello R: α-Globin Gene Quadruplication and Heterozygous β-Thalassemia: A Not So Rare Cause of Thalassemia Intermedia. Acta haematologica 2013, 131: 162 [PMID: 24217654] ORI2013
  11. Lucarelli G, Isgro`, A, Sodani P, Gaziev, J: Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Anemia. Cold Spring Harb Perspect Med 2012, 2: a011825 [PMID: 22553502] LUC2012
  12. Voskaridou E, Ladis V, Kattamis A, Hassapopoulou E, Economou M, Kourakli A, Maragkos K, Kontogianni K, Lafioniatis S, Vrettou E, Koutsouka F, Papadakis A, Mihos A, Eftihiadis E, Farmaki K, Papageorgiou O, Tapaki G, Maili P, Theohari M, Drosou M, Kartasis Z, Aggelaki M, Basileiadi A, Adamopoulos I, Lafiatis I, Galanopoulos A, Xanthopoulidis G, Dimitriadou E, Mprimi A, Stamatopoulou M, Haile ED, Tsironi M, Anastasiadis A, Kalmanti M, Papadopoulou M, Panori E, Dimoxenou P, Tsirka A, Georgakopoulos D, Drandrakis P, Dionisopoulou D, Ntalamaga A, Davros I, Karagiorga M, on behalf of the Greek Haemoglobinopathies Study Group: A national registry of haemoglobinopathies in Greece: Deducted demographics, trends in mortality and affected births. Annals of hematology 2012, epub ahead of print [DOI: 10.1007/s00277-012-1465-7] VOS2012
  13. Rachmilewitz EA, Giardina PJ: How I treat thalassemia. Blood 2011, 118: 3479 [PMID: 21813448] RAC2011
  14. Kelly MJ, Pennarola BW, Rodday AM, Parsons SK, on behalf of the Journeys to Recovery Study, the HSCT-CHESS™ Study: Health-related quality of life (HRQL) in children with sickle cell disease and thalassemia following hematopoietic stem cell transplant (HSCT). Pediatric blood & cancer 2011 Dec 19; [PMID: 22183952] KEL2011
  15. Ginzburg Y, Rivella S: {beta}-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood 2011, 118: 4321 [PMID: 21768301] GIN2011
  16. Kohne E, Kleihauer E: Hämoglobinopathien - eine Langzeitstudie über vier Jahrzehnte. Dtsch Arztebl Int 2010, 107: 65 [DOI: 10.3238/arztebl.2010.0065] KOH2010
  17. Borgna-Pignatti C: Modern treatment of thalassaemia intermedia. British journal of haematology 2007, 138: 291 [PMID: 17565568] BOR2007
  18. Rund D, Rachmilewitz E: Beta-thalassemia. The New England journal of medicine 2005, 353: 1135 [PMID: 16162884] RUN2005
  19. Vetter B, Schwarz C, Kohne E, Kulozik AE: Beta-thalassaemia in the immigrant and non-immigrant German populations. British journal of haematology 1997, 97: 266 [PMID: 9163586] VET1997
Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT) (2013) (2.7 MB)
Leitlinie der Thalassaemia international federation zu nicht-transfusionsabhängigen Thalassämien.

Literatur zur Aplastischen Anämie

  1. Yoshimi A, Strahm B, Baumann I, Furlan I, Schwarz S, Teigler-Schlegel A, Walther JU, Schlegelberger B, Göhring G, Nöllke P, Führer M, Niemeyer CM: Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia. Biology of blood and marrow transplantation 2014, 20: 425 [PMID: 24316460] YOS2014
  2. Yoshimi A, Niemeyer CM, Führer MM, Strahm B: Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children. Blood 2013, 121: 860 [PMID: 23372153] YOS2013
  3. Urban C, Lackner H, Müller E, Benesch M, Strenger V, Sovinz P, Schwinger W: Stem cell transplantation in 6 children with parvovirus B19- induced severe aplastic anaemia or myelodysplastic syndrome. Klinische Padiatrie 2011, 223: 332 [PMID: 22052631] URB2011
  4. Niemeyer CM, Baumann I: Classification of childhood aplastic anemia and myelodysplastic syndrome. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2011, 2011, 84 [PMID: 22160017] NIE2011

Chronischen Anämien

  1. Ganz T: Iron and infection. International journal of hematology 2018, 107: 7 [PMID: 29147843] GAN2017
  2. Agrawal AK, Hsu E, Quirolo K, Neumayr LD, Flori HR: Red blood cell transfusion in pediatric patients with severe chronic anemia: How slow is necessary? Pediatric blood & cancer 2012, 58: 466 [PMID: 21793178] AGR2012

Literatur zur refraktären Eisenmangelanämie

  1. Lehmberg K, Grosse R, Muckenthaler MU, Altamura S, Nielsen P, Schmid H, Graubner U, Oyen F, Zeller W, Schneppenheim R, Janka GE: Administration of recombinant erythropoietin alone does not improve the phenotype in iron refractory iron deficiency anemia patients. Annals of hematology 2013, 92: 387 [PMID: 23180434] LEH2013

Erkrankungen der Leukozyten

Literatur zu chronischen Neutropenien

Pubmed

  1. Fioredda F, Skokowa J, Tamary H, Spanoudakis M, Farruggia P, Almeida A, Guardo D, Höglund P, Newburger PE, Palmblad J, Touw IP, Zeidler C, Warren AJ, Dale DC, Welte K, Dufour C, Papadaki HA: The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action. HemaSphere 2023, 7:e872 [PMID: 37008163] FIO2023
  2. Pogozhykh D, Yilmaz Karapinar D, Klimiankou M, Gerschmann N, Ebetsberger-Dachs G, Palmblad J, Carlsson G, Masmas T, Kinsey S, Bartels M, Mellor-Heineke S, Welte K, Skokowa J, Zeidler C: HAX1-related congenital neutropenia: Long-term observation in paediatric and adult patients enrolled in the European branch of the Severe Chronic Neutropenia International Registry (SCNIR). British journal of haematology 2023, 202: 393 [PMID: 37193639] POG2023
  3. Dale DC, Bolyard AA, Steele LA, Zeidler C, Welte K, Severe Chronic Neutropenia International Registry: Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry. Current opinion in hematology 2020, 27: 18 [PMID: 31764167] DAL2020
  4. Mir P, Klimiankou M, Findik B, Hähnel K, Mellor-Heineke S, Zeidler C, Skokowa J, Welte K: New insights into the pathomechanism of cyclic neutropenia. Annals of the New York Academy of Sciences 2020, 1466, 83 [PMID: 32083314] MIR2020
  5. Papadaki HA, Mavroudi I, Almeida A, Bux J, Cichy J, Dale DC, Donadieu J, Höglund P, Karanfilski O, Mecucci C, Palmblad J, Skokowa J, Stamatopoulos K, Touw I, Warren AJ, Welte K, Zeidler C, Dufour C: Congenital and Acquired Chronic Neutropenias: Challenges, Perspectives and Implementation of the EuNet-INNOCHRON Action. HemaSphere 2020, 4:e406 [PMID: 32647804] PAP2020
  6. Dale DC, Bolyard AA, Marrero T, Kelley ML, Makaryan V, Tran E, Leung J, Boxer LA, Kishnani PS, Austin S, Wanner C, Ferrecchia IA, Khalaf D, Maze D, Kurtzberg J, Zeidler C, Welte K, Weinstein DA: Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor. Current opinion in hematology 2019, 26: 16 [PMID: 30451720] DAL2019
  7. Klimiankou M, Uenalan M, Kandabarau S, Nustede R, Steiert I, Mellor-Heineke S, Zeidler C, Skokowa J, Welte K: Ultra-Sensitive CSF3R Deep Sequencing in Patients With Severe Congenital Neutropenia. Frontiers in immunology 2019, 10: 116 [PMID: 30891028] KLI2019
  8. Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K: Severe congenital neutropenias. Nature reviews 2017, 3: 17032 [PMID: 28593997] SKO2017
  9. Koch C, Samareh B, Morishima T, Mir P, Kanz L, Zeidler C, Skokowa J, Welte K: GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling. Annals of hematology 2017, 96: 345 [PMID: 27966038] KOC2017
  10. Nustede R, Klimiankou M, Klimenkova O, Kuznetsova I, Zeidler C, Welte K, Skokowa J: ELANE mutant-specific activation of different UPR pathways in congenital neutropenia. British journal of haematology 2016, 172: 219 [PMID: 26567890] NUS2016
  11. Klimiankou M, Mellor-Heineke S, Klimenkova O, Reinel E, Uenalan M, Kandabarau S, Skokowa J, Welte K, Zeidler C: Two cases of cyclic neutropenia with acquired CSF3R mutations, with 1 developing AML. Blood 2016, 127: 2638 [PMID: 27030388] KLI2016
  12. Klimiankou M, Klimenkova O, Uenalan M, Zeidler A, Mellor-Heineke S, Kandabarau S, Skokowa J, Zeidler C, Welte K: GM-CSF stimulates granulopoiesis in a congenital neutropenia patient with loss-of-function biallelic heterozygous CSF3R mutations. Blood 2015/126: 1865 [PMID: 26324699] KLI2015
  13. Skokowa J, Steinemann D, Katsman-Kuipers JE, Zeidler C, Klimenkova O, Klimiankou M, Unalan M, Kandabarau S, Makaryan V, Beekman R, Behrens K, Stocking C, Obenauer J, Schnittger S, Kohlmann A, Valkhof MG, Hoogenboezem R, Göhring G, Reinhardt D, Schlegelberger B, Stanulla M, Vandenberghe P, Donadieu J, Zwaan CM, Touw IP, van den Heuvel-Eibrink MM, Dale DC, Welte K: Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. Blood 2014, 123: 2229 [PMID: 24523240] SKO2014
  14. Zeidler C, Grote UA, Nickel A, Brand B, Carlsson G, Cortesão E, Dufour C, Duhem C, Notheis G, Papadaki HA, Tamary H, Tjønnfjord GE, Tucci F, Van Droogenbroeck J, Vermylen C, Voglova J, Xicoy B, Welte K: Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry. Haematologica 2014, 99: 1395 [PMID: 24997149] ZEI2014
  15. Zeidler C: [Primary and secondary neutropenia]. Zeitschrift fur Rheumatologie 2013, 72: 663 [PMID: 23949279] ZEI2013
  16. Skokowa J, Klimiankou M, Klimenkova O, Lan D, Gupta K, Hussein K, Carrizosa E, Kusnetsova I, Li Z, Sustmann C, Ganser A, Zeidler C, Kreipe HH, Burkhardt J, Grosschedl R, Welte K: Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis. Nature medicine 2012, 18: 1550 [PMID: 23001182] SKO2012
  17. Beekman R, Valkhof MG, Sanders MA, van Strien PM, Haanstra JR, Broeders L, Geertsma-Kleinekoort WM, Veerman AJ, Valk PJ, Verhaak RG, Löwenberg B, Touw IP: Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood 2012, 119: 5071 [PMID: 22371884] BEE2012
  18. Kelly MJ, Pennarola BW, Rodday AM, Parsons SK, on behalf of the Journeys to Recovery Study, the HSCT-CHESS™ Study: Health-related quality of life (HRQL) in children with sickle cell disease and thalassemia following hematopoietic stem cell transplant (HSCT). Pediatric blood & cancer 2011 Dec 19; [PMID: 22183952] KEL2011
  19. Klein C, Welte K: Genetic insights into congenital neutropenia. Clinical reviews in allergy & immunology 2010, 38: 68 [PMID: 19440858] KLE2010
  20. Boztug K, Welte K, Zeidler C, Klein C: Congenital neutropenia syndromes. Immunology and allergy clinics of North America 2008, 28: 259-75, vii-viii [PMID: 18424332] BOZ2008
  21. Link DC, Kunter G, Kasai Y, Zhao Y, Miner T, McLellan MD, Ries RE, Kapur D, Nagarajan R, Dale DC, Bolyard AA, Boxer LA, Welte K, Zeidler C, Donadieu J, Bellanné-Chantelot C, Vardiman JW, Caligiuri MA, Bloomfield CD, DiPersio JF, Tomasson MH, Graubert TA, Westervelt P, Watson M, Shannon W, Baty J, Mardis ER, Wilson RK, Ley TJ: Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood 2007, 110: 1648 [PMID: 17494858] LIN2007
  22. Bohn G, Welte K, Klein C: Severe congenital neutropenia: new genes explain an old disease. Current opinion in rheumatology 2007, 19: 644 [PMID: 17917547] BOH2007
  23. Gerth HU, Juergens KU, Dirksen U, Gerss J, Schober O, Franzius C: Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007, 48: 1932 [PMID: 18006618] GER2007
  24. Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Fier C, Freedman M, Kannourakis G, Kinsey S, Schwinzer B, Zeidler C, Welte K, Dale DC, Severe Chronic Neutropenia International Registry: The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006, 107: 4628 [PMID: 16497969] ROS2006
  25. James RM, Kinsey SE: The investigation and management of chronic neutropenia in children. Archives of disease in childhood 2006, 91: 852 [PMID: 16990357] JAM2006
  26. Cotter M, Gulmann C, Jeffers M, Smith OP: Increased bone marrow angiogenesis in children with severe chronic neutropenia treated with granulocyte colony-stimulating factor. Journal of pediatric hematology/oncology 2004, 26: 504 [PMID: 15284588] COT2004
  27. Zeidler C, Welte K: Kostmann syndrome and severe congenital neutropenia. Seminars in hematology 2002, 39: 82 [PMID: 11957189] ZEI2002
  28. Dale DC, Bolyard AA, Aprikyan A: Cyclic neutropenia. Seminars in hematology 2002, 39: 89 [PMID: 11957190] DAL2002
  29. Cottle TE, Fier CJ, Donadieu J, Kinsey SE: Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor. Seminars in hematology 2002, 39: 134 [PMID: 11957197] COT2002
  30. Boztug K, Welte K, Zeidler C, Klein C: Congenital neutropenia syndromes. Immunology and allergy clinics of North America 2008, 28: 259-75, vii-viii [PMID: 18424332] BOX2002
  31. Schiller M, Böhm M, Zeidler C, Germeshausen M, Welte K, Luger TA, Bonsmann G: [Cyclic neutropenia. Detection of a mutation in the gene for neutrophil elastase (ELA2)]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2001, 52: 790 [PMID: 11572070] SCH2001j
  32. Carlsson G, Fasth A: Infantile genetic agranulocytosis, morbus Kostmann: presentation of six cases from the original . Acta paediatrica (Oslo, Norway : 1992) 2001, 90: 757 [PMID: 11519978] CAR2001
  33. Zeidler C, Boxer L, Dale DC, Freedman MH, Kinsey S, Welte K: Management of Kostmann syndrome in the G-CSF era. British journal of haematology 2000, 109: 490 [PMID: 10886193] ZEI2000a
  34. Zeidler C, Schwinzer B, Welte K: [Severe congenital neutropenia: trends in diagnosis and therapy]. Klinische Padiatrie 2000, 212: 145 [PMID: 10994541] ZEI2000
  35. Horwitz M, Benson KF, Person RE, Aprikyan AG, Dale DC: Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nature genetics 1999, 23: 433 [PMID: 10581030] HOR1999

Erkrankungen der Thrombozyten

Literatur zur Idiopathischen Immunthrombozytopenie (ITP)

  1. Schifferli A, Moulis G, Godeau B, Leblanc T, Aladjidi N, Michel M, Leverger G, Elalfy M, Grainger J, Chitlur M, Heiri A, Holzhauer S, Le Gavrian G, Imbach P, Kühne T: Adolescents and young adults with newly diagnosed primary immune thrombocytopenia. Haematologica 2023, 108: 2783 [PMID: 37051753] SCH2023f
  2. Matzdorff A, Alesci SR, Gebhart J, Holzhauer S, Hütter-Krönke ML, Kühne T, Meyer O, Ostermann H, Pabinger I, Rummel M, Sachs UJ, Stauch T, Trautmann-Grill K, Wörmann B: Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment - Recommendations from an Expert Group from Austria, Germany, and Switzerland. Oncology research and treatment 2023, 46 Suppl 2: 5 [PMID: 36787705] MAT2023
  3. Mayer B, Salama A: Successful treatment of bleeding with tranexamic acid in a series of 12 patients with immune thrombocytopenia. Vox sanguinis 2017, 112: 767 [PMID: 28952160] MAY2017
  4. Cines DB, Levine LD: Thrombocytopenia in pregnancy. Hematology. American Society of Hematology 2017, 2017, 144 [PMID: 29222249] DOU2017
  5. Cuker A, Neunert CE: How I treat refractory immune thrombocytopenia. Blood 2016, 128: 1547 [PMID: 27053529] CUK2016
  6. Rohmer B, Valla FV, Baleydier F, Launay V, Dommange-Romero F, Pondarré C: Newly Diagnosed Immune Thrombocytopenic Purpura in Childhood: Successful Implementation of a Limited Intervention Strategy in the Setting of Pediatric Emergency Care. The Journal of pediatrics 2014, Epub ahead of print [PMID: 25454932] ROH2014
  7. Seidel MG, Urban C, Sipurzynski J, Beham-Schmid C, Lackner H, Benesch M: High response rate but short-term effect of romiplostim in paediatric refractory chronic immune thrombocytopenia. British journal of haematology 2014, E-pub ahead of print [PMID: 24484542] SEI2014
  8. Lorenzana A, Armin S, Sharma A, Allarakhia I, Witkowski A: Cerebral Infarctions After Intravenous Immunoglobulin Therapy for ITP in a Child. Pediatric neurology 2014, 50: 188 [PMID: 24262342] LOR2014
  9. Labarque V, Van Geet C: Clinical practice: immune thrombocytopenia in paediatrics. European journal of pediatrics 2014, 173: 163 [PMID: 24390128] LAB2014
  10. Neunert CE: Individualized treatment for immune thrombocytopenia: predicting bleeding risk. Seminars in hematology 2013, 50 Suppl 1:S55 [PMID: 23664518] NEU2013
  11. Grace RF, Bennett CM, Ritchey AK, Jeng M, Thornburg CD, Lambert MP, Neier M, Recht M, Kumar M, Blanchette V, Klaassen RJ, Buchanan GR, Kurth MH, Nugent DJ, Thompson AA, Stine K, Kalish LA, Neufeld EJ: Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia. Pediatric blood & cancer 2012, 58: 221 [PMID: 21674758] GRA2012a
  12. George JN: Children with ITP: Looking beyond the platelet count. Pediatric blood & cancer 2012, 58: 323 [PMID: 21898785] GEO2012
  13. Grace RF, Long M, Kalish LA, Neufeld EJ: Applicability of 2009 international consensus terminology and criteria for immune thrombocytopenia to a clinical pediatric population. Pediatric blood & cancer 2012, 58: 216 [PMID: 21674757] GRA2012
  14. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ: International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010, 115: 168 [PMID: 19846889] PRO2010
  15. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN: Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009, 113: 2386 [PMID: 19005182] ROD2009
  16. Laws HJ, Janssen G, Borkhardt A: Reassessment of treatment modalities for paediatric patients with chronic immune thrombocytopenia. Hamostaseologie 2009, 29: 171 [PMID: 19404521] LAW2009
  17. Salama A, Kiesewetter H, Kalus U, Movassaghi K, Meyer O: Massive platelet transfusion is a rapidly effective emergency treatment in patients with refractory autoimmune thrombocytopenia. Thrombosis and haemostasis 2008, 100: 762 [PMID: 18989518] SAL2008
  18. Rajantie J, Zeller B, Treutiger I, Rosthöj S, NOPHO ITP working group and five national study groups: Vaccination associated thrombocytopenic purpura in children. Vaccine 2007, 25: 1838 [PMID: 17126957] RAJ2007
  19. Imbach P, Kühne T, Müller D, Berchtold W, Zimmerman S, Elalfy M, Buchanan GR: Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatric blood & cancer 2006, 46: 351 [PMID: 16086422] IMB2006a
  20. Tarantino MD: The treatment of immune thrombocytopenic purpura in children. Current hematology reports 2006, 5: 89 [PMID: 16537052] TAR2006
  21. Buchanan GR, Adix L: Current challenges in the management of children with idiopathic thrombocytopenic purpura. Pediatric blood & cancer 2006, 47(5 Suppl): 681 [PMID: 16933253] BUN2006
  22. Rosthøj S, Hedlund-Treutiger I, Rajantie J, Zeller B, Jonsson OG, Elinder G, Wesenberg F, Henter JI, NOPHO ITP Working Group: Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: A prospective Nordic study of an unselected cohort. The Journal of pediatrics 2003, 143: 302 [PMID: 14517509] ROS2003
  23. Buchanan GR, Adix L: Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. The Journal of pediatrics 2002, 141: 683 [PMID: 12410198] BUN2002
  24. Bolton-Maggs PH, Dickerhoff R, Vora AJ: The nontreatment of childhood ITP (or . Seminars in thrombosis and hemostasis 2001, 27: 269 [PMID: 11446660] BOL2001
  25. Dickerhoff R, von Rücker A: The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. J Pediatr 2000, 137: 629 [DOI: 10.1067/mpd.2000.110123] DIC2000
  26. Lilleyman JS: Management of childhood idiopathic thrombocytopenic purpura. British journal of haematology 1999, 105: 871 [PMID: 10554795] LIL1999
  27. Kühne T, Freedman J, Semple JW, Doyle J, Butchart S, Blanchette VS: Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura. The Journal of pediatrics 1997, 130: 17 [PMID: 9003846] KUE1997
  28. Kühl J: Ergebnisse der Pädiatrischen Neuro-Onkologie III, Berichte von der Tagung der Arbeitsgruppe für Hirntumoren im Kindesalter der Gesellschaft für Pädiatrische Onkologie und Hämatologie und der Gesellschaft für Neuropädiatrie am 13./14. Juni 1997 in Würzburg. GPOH 1997 KUE1997

Literatur zu Thrombozytenfunktionsstörungen

Pubmed

  1. Graf N, Bergeron C, Brok J, de Camargo B, Chowdhury T, Furtwängler R, Gessler M, Godzinski J, Pritchard-Jones K, Ramirez-Villar GL, Rübe C, Sandstedt B, Schenk JP, Spreafico F, Sudour-Bonnange H, van Tinteren H, Verschuur A, Vujanic G, van den Heuvel-Eibrink MM: Fifty years of clinical and research studies for childhood renal tumors within the International Society of Pediatric Oncology (SIOP). Annals of oncology 2021, 32: 1327 [PMID: 34416363] GRA2021
  2. Grainger JD, Kühne T, Hippenmeyer J, Cooper N: Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia. Annals of hematology 2021, Online ahead of print [PMID: 34308495] GRA2021
  3. Knöfler R, Eberl W, Schulze H, Bakchoul T, Bergmann F, Gehrisch S, Geisen C, Gottstein S, Halimeh S, Harbrecht U, Kappert G, Kirchmaier C, Kehrel B, Lösche W, Krause M, Mahnel R, Meyer O, Pilgrimm AK, Pillitteri D, Rott H, Santoso S, Siegemund A, Schambeck C, Scheer M, Schmugge M, Scholl T, Strauss G, Zieger B, Zotz R, Hermann M, Streif W: [Diagnosis of inherited diseases of platelet function. Interdisciplinary S2K guideline of the Permanent Paediatric Committee of the Society of Thrombosis and Haemostasis Research (GTH e. V.)]. Hamostaseologie 2014, 34: 201 [PMID: 24903476] KNO2014
  4. Streif W, Knöfler R, Eberl W, Andres O, Bakchoul T, Bergmann F, Beutel K, Dittmer R, Gehrisch S, Gottstein S, Halimeh S, Haselböck J, Hassenpflug WA, Heine S, Holzhauer S, King S, Kirchmaier CM, Krause M, Kreuz W, Lösche W, Mahnel R, Maurer M, Nimtz-Talaska A, Olivieri M, Rott H, Schambeck ChM, Schedel A, Schilling FH, Schmugge M, Schneppenheim R, Scholz U, Scholz T, Schulze H, Siegemund A, Strauß G, Sykora KW, Wermes C, Wiegering V, Wieland I, Zieger B, Zotz RB, Paediatric Committee of the Society of Thrombosis and Haemostasis Research: [Therapy of inherited diseases of platelet function. Interdisciplinary S2K guideline of the Permanent Paediatric Committee of the Society of Thrombosis and Haemostasis Research (GTH e. V.)]. Hamostaseologie 2014, 34: 269-75, quiz 276 [PMID: 25370176] STR2014
  5. Limperger V, Klostermeier UC, Kenet G, Holzhauer S, Alhenc Gelas M, Finckh U, Junker R, Heller C, Zieger B, Kurnik K, Knöfler R, Mesters R, Halimeh S, Nowak-Göttl U: Clinical and laboratory characteristics of children with venous thromboembolism and protein C-deficiency: an observational Israeli-German cohort study. British journal of haematology 2014, 167: 385 [PMID: 25039884] LIM2014
  6. Halimeh S: Menorrhagia and bleeding disorders in adolescent females. Hamostaseologie 2012, 32: 45 [PMID: 22127528] HAL2012
  7. Nurden AT, Freson K, Seligsohn U: Inherited platelet disorders. Haemophilia 2012, 18 Suppl 4: 154 [PMID: 22726100] NUR2012
  8. Bidlingmaier C, Olivieri M,Kurnik, K: Hautblutungen bei Kindern Ist es eine Gerinnungsstörung? Monatsschrift Kinderheilkunde 2012, 160 , 538 [DOI: 10.1007/s00112-012-2631-7] BID2012
  9. Tauer JT, Gneuss A, Lohse JE, Jürgens T, Knöfler R: Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy. Klinische Padiatrie 2011, 223: 169 [PMID: 21509710] TAU2011
  10. Althaus K, Najm J, Greinacher A: MYH9 Related Platelet Disorders - Often Unknown and Misdiagnosed. Klinische Padiatrie 2011, 223, 120 [DOI: 10.1055/s-0031-1275664] ALT2011
  11. Cox K, Price V, Kahr WH: Inherited platelet disorders: a clinical approach to diagnosis and management. Expert review of hematology 2011, 4: 455 [PMID: 21801136] COX2011
  12. Schädlich D, Friebel D, Schallner J, Gehrisch S, Siegert G, Kuhlisch E, Knöfler R: [Evaluation of haemostasis in children treated with valproic acid]. Hamostaseologie 2010, 30 Suppl 1:S132 [PMID: 21042677] SCH2010h
  13. Knöfler R, Streif W: Strategies in Clinical and Laboratory Diagnosis of Inherited Platelet Function Disorders in Children. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2010, 37: 231 [PMID: 21113245] KNO2010
  14. Lohse J, Schweigel J, Naeke A, Lee-Kirsch MA, Siegert G, Bergmann S, Kuhlisch E, Suttorp M, Knöfler R: Platelet function in obese children and adolescents. Hamostaseologie 2010, 30 Suppl 1:S126 [PMID: 21042676] LOH2010
  15. Streif W, Knöfler R, Eberl W: Inherited disorders of platelet function in pediatric clinical practice: a diagnostic challenge. Klinische Padiatrie 2010, 222: 203 [PMID: 20514633] STR2010
  16. Rolf N, Bugert P, Gehrisch S, Siegert G, Suttorp M, Knöfler R: [Clinical and laboratory aspects of the Aspirin-like defect as hereditary thrombocytopathy]. Hamostaseologie 2009, 29: 177 [PMID: 19404514] ROL2009
  17. Hanebutt FL, Rolf N, Loesel A, Kuhlisch E, Siegert G, Knoefler R: Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders. Haemophilia 2008, 14: 524 [PMID: 18284449] HAN2008
  18. Knöfler R, Olivieri M, Weickardt S, Eberl W, Streif W, THROMKID Studiengruppe der Gesellschaft für Thrombose- und Hämostaseforschung eV: [First results of the THROMKID study: a quality project for the registration of children und adolescents with hereditary platelet function defects in Germany, Austria, and Switzerland]. Hamostaseologie 2007, 27: 48 [PMID: 17279276] KNO2007
  19. Zotz R B, Scharf R E: Rekombinanter Faktor VIIa bei Patienten mit Plättchenfunktionsstörungen oder Thrombozytopenien. Hämostaseologie 2007, 27; 237 [ISSN: 0720-9355] ZOT2007
  20. Tiede A: [Perioperative hemostasis management]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 2007, 78: 69-79; quiz 80 [PMID: 17216504] TIE2007
  21. Dale DC, Bolyard AA, Schwinzer BG, Pracht G, Bonilla MA, Boxer L, Freedman MH, Donadieu J, Kannourakis G, Alter BP, Cham BP, Winkelstein J, Kinsey SE, Zeidler C, Welte K: The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report. Supportive cancer therapy 2006 Jul 1; 3: 220 [PMID: 18632498] DAL2006
  22. Gadner H, Gaedicke G, Niemeyer CH, Ritter J (Hrsg): Pädiatrische Hämatologie und Onkologie. Springer-Verlag 2006 [URI: http://www.springer.com/ medicine/ pediatrics/ book/ 978-3-540-03702-6] GAD2006
  23. Hohlfeld Th: Hämostasestörungen durch Analgetika, Antiphlogistika und Antirheumatika. Hämostasiologie 2001, 01, 22 [URI: http://www.schattauer.de/ de/ magazine/ uebersicht/ zeitschriften-a-z/ haemostaseologie/ inhalt/ archiv/ issue/ 509/ manuscript/ 1671/ show.html] HOH2001

Thrombophilie

  1. Holzhauer S, Goldenberg NA, Junker R, Heller C, Stoll M, Manner D, Mesters R, Krümpel A, Stach M, Nowak-Göttl U: Inherited thrombophilia in children with venous thromboembolism and the familial risk of thromboembolism: an observational study. Blood 2012, 120: 1510 [PMID: 22581447] HOL2012

Gerinnungsstörungen

Literatur zur Hämophilie

  1. Klamroth R, Holzhauer S, Zimmermann R, Heller C, Kurnik K, Beriate® Pharmacovigilance Group: Beriate® P in the treatment of patients with haemophilia A: results of a long-term pharmacovigilance study. Thrombosis research 2014, 134 Suppl 1:S16 [PMID: 24418255] KLA2014
  2. Halimeh S, Bidlingmaier C, Heller C, Gutsche S, Holzhauer S, Kenet G, Kurnik K, Manner D, Iorio A, Nowak-Göttl U: Risk factors for high-titer inhibitor development in children with hemophilia A: results of a cohort study. BioMed research international 2013, 2013, 901975 [PMID: 24199202] HAL2013
  3. Mannucci PM, Mancuso ME, Santagostino E: How we choose factor VIII to treat hemophilia. Blood 2012, 119: 4108 [PMID: 22411872] SCI2012

Literatur zur Diffentialdiagnostik

  1. Bidlingmaier C, Olivieri M,Kurnik, K: Hautblutungen bei Kindern Ist es eine Gerinnungsstörung? Monatsschrift Kinderheilkunde 2012, 160 , 538 [DOI: 10.1007/s00112-012-2631-7] BID2012

Literatur zum Von Willebrand Syndrom

  1. Tiede A, Rand JH, Budde U, Ganser A, Federici AB: How I treat the acquired von Willebrand syndrome. Blood 2011, 117: 6777 [PMID: 21540459] TIE2011

Hämophagozytische Lymphhistiozytose

Literatur zur Hämophagozytischen Lymphhistiozytose

  1. Ehl S, von Bahr Greenwood T, Bergsten E, Fischer A, Henter JI, Hines M, Lehmberg K, Janka G, Moshous D, Nichols KE: Is neutralization of IFN-γ sufficient to control inflammation in HLH? Pediatric blood & cancer 2021, 68:e28886 [PMID: 33405364] EHL2021
  2. Wegehaupt O, Wustrau K, Lehmberg K, Ehl S: Cell Versus Cytokine - Directed Therapies for Hemophagocytic Lymphohistiocytosis (HLH) in Inborn Errors of Immunity. Frontiers in immunology 2020, 11: 808 [PMID: 32457750] WEG2020
  3. Ehl S, Astigarraga I, von Bahr Greenwood T, Hines M, Horne A, Ishii E, Janka G, Jordan MB, La Rosée P, Lehmberg K, Machowicz R, Nichols KE, Sieni E, Wang Z, Henter JI: Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society. The journal of allergy and clinical immunology. In practice 2018, 6: 1508 [PMID: 30201097] EHL2018
  4. Ehl S, Bogdan C, Niehues T, Borchard G, Baumann U, Hecht J, Koch j, Neubert J, Wiese-Pochelt K, Zepp F: Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen.(II) Impfen bei 1. Primären Immundefekterkrankungen und 2. HIV-Infektion. Bundesgesundheitsblatt 2018, 61: 1034 [PMID: 30062550] EHL2018
  5. Ehl S: Etoposide for HLH: the limits of efficacy. Blood 2017, 130: 2692 [PMID: 29269529] EHL2017
  6. Trottestam H, Berglöf E, Horne A, Onelöv E, Beutel K, Lehmberg K, Sieni E, Silfverberg T, Aricò M, Janka G, Henter JI: Risk factors for early death in children with haemophagocytic lymphohistiocytosis. Acta paediatrica (Oslo, Norway : 1992) 2012, 101: 313 [PMID: 22017632] TRO2012
  7. Pagel J, Beutel K, Lehmberg K, Koch F, Maul-Pavicic A, Rohlfs AK, Al-Jefri A, Beier R, Bomme Ousager L, Ehlert K, Gross-Wieltsch U, Jorch N, Kremens B, Pekrun A, Sparber-Sauer M, Mejstrikova E, Wawer A, Ehl S, zur Stadt U, Janka G: Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood 2012, 119: 6016 [PMID: 22451424] PAG2012
  8. Janka GE: Familial and acquired hemophagocytic lymphohistiocytosis. Annual review of medicine 2012, 63: 233 [PMID: 22248322] JAN2012
  9. Trottestam H, Horne A, Aricò M, Egeler RM, Filipovich AH, Gadner H, Imashuku S, Ladisch S, Webb D, Janka G, Henter JI, Histiocyte Society: Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 2011, 118: 4577 [PMID: 21900192] TRO2011
  10. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL: How I treat hemophagocytic lymphohistiocytosis. Blood 2011, 118: 4041 [PMID: 21828139] JOR2011
  11. Janka GE: Hemophagocytic syndromes. Blood reviews 2007, 21: 245 [PMID: 17590250] JAN2007a

Noonan Syndrom

Literatur zum Noonan Syndrom

  1. Briggs BJ, Dickerman JD: Bleeding disorders in Noonan syndrome. Pediatric blood & cancer 2012, 58: 167 [PMID: 22012616] BRI2012